A citation-based method for searching scientific literature

Enrico Cappellin, Rosalba Gatti, Giorgia Antonelli, Giuseppe Soldà, Eugenio Ragazzi, Elio Franco De Palo, Paolo Spinella. J Cardiovasc Med (Hagerstown) 2013
Times Cited: 4







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Furin-mediated processing of Pro-C-type natriuretic peptide.
Chengliang Wu, Faye Wu, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2003
143
50

Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients.
Alexander Koch, Sebastian Voigt, Edouard Sanson, Hanna Dückers, Andreas Horn, Henning W Zimmermann, Christian Trautwein, Frank Tacke. Crit Care 2011
43
50

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
A J Stingo, A L Clavell, D M Heublein, C M Wei, M R Pittelkow, J C Burnett. Am J Physiol 1992
237
50

Inflammatory cytokines and NT-proCNP in Parkinson's disease patients.
Dariusz Koziorowski, Ryszard Tomasiuk, Stanisław Szlufik, Andrzej Friedman. Cytokine 2012
73
50

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
50

Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
Dirk J Lok, Ijsbrand T Klip, Adriaan A Voors, Sjoukje I Lok, Pieta W Bruggink-André de la Porte, Hans L Hillege, Tiny Jaarsma, Dirk J van Veldhuisen, Peter van der Meer. Eur J Heart Fail 2014
30
50

Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis.
Charalambos Vlachopoulos, Nikolaos Ioakeimidis, Dimitrios Terentes-Printzios, Konstantinos Aznaouridis, Katerina Baou, Athanasios Bratsas, Georgios Lazaros, Christodoulos Stefanadis. Atherosclerosis 2010
25
50



Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosis.
Alexander Koch, Henning W Zimmermann, Christer Baeck, Carlo Schneider, Eray Yagmur, Christian Trautwein, Frank Tacke. Clin Biochem 2012
10
50


A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs.
Shen Luo, Kurt Michler, Paul Johnston, Peter W Macfarlane. J Electrocardiol 2004
293
25


Congestive heart failure and QRS duration: establishing prognosis study.
Heather J Shenkman, Vijayamalini Pampati, Akshay K Khandelwal, John McKinnon, David Nori, Scott Kaatz, Keisha R Sandberg, Peter A McCullough. Chest 2002
179
25



Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress.
Brian R Clapp, Aroon D Hingorani, Rajesh K Kharbanda, Vidya Mohamed-Ali, Jeffrey W Stephens, Patrick Vallance, Raymond J MacAllister. Cardiovasc Res 2004
174
25

What clinicians should know about the QT interval.
Sana M Al-Khatib, Nancy M Allen LaPointe, Judith M Kramer, Robert M Califf. JAMA 2003
399
25

QT prolongation and dispersion in myocardial ischemia and infarction.
G Tomassoni, E Pisanó, L Gardner, M W Krucoff, A Natale. J Electrocardiol 1998
17
25

Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
S Toshima, A Hasegawa, M Kurabayashi, H Itabe, T Takano, J Sugano, K Shimamura, J Kimura, I Michishita, T Suzuki,[...]. Arterioscler Thromb Vasc Biol 2000
294
25


Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study.
Amanda J Cox, Amir Azeem, Joseph Yeboah, Elsayed Z Soliman, Shivani R Aggarwal, Alain G Bertoni, J Jeffrey Carr, Barry I Freedman, David M Herrington, Donald W Bowden. Diabetes Care 2014
51
25


Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes.
Xiang Li, Hui Ren, Zhang-rong Xu, Yan-jun Liu, Xiao-pin Yang, Jian-qin Liu. Exp Diabetes Res 2012
21
25

Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.
Piero Ruggenenti, Esteban Porrini, Nicola Motterlini, Annalisa Perna, Aneliya Parvanova Ilieva, Ilian Petrov Iliev, Alessandro Roberto Dodesini, Roberto Trevisan, Antonio Bossi, Giuseppe Sampietro,[...]. J Am Soc Nephrol 2012
64
25

Cardiovascular morbidity and mortality associated with the metabolic syndrome.
B Isomaa, P Almgren, T Tuomi, B Forsén, K Lahti, M Nissén, M R Taskinen, L Groop. Diabetes Care 2001
25

QT interval: how to measure it and what is "normal".
Ilan Goldenberg, Arthur J Moss, Wojciech Zareba. J Cardiovasc Electrophysiol 2006
321
25

Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss.
M J Carella, S L Mantz, D R Rovner, P W Willis, V V Gossain, R R Bouknight, G S Ferenchick. Int J Obes Relat Metab Disord 1996
51
25

QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.
E G Schouten, J M Dekker, P Meppelink, F J Kok, J P Vandenbroucke, J Pool. Circulation 1991
501
25


Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.
K Yamagata, K Ishida, T Sairenchi, H Takahashi, S Ohba, T Shiigai, M Narita, A Koyama. Kidney Int 2007
368
25


Management of chronic heart failure in adults: synopsis of the National Institute For Health and clinical excellence guideline.
Jonathan Mant, Abdallah Al-Mohammad, Sharon Swain, Philippe Laramée. Ann Intern Med 2011
39
25

Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
Daisuke Watabe, Junichiro Hashimoto, Rieko Hatanaka, Tomohiro Hanazawa, Hiromi Ohba, Takayoshi Ohkubo, Masahiro Kikuya, Kazuhito Totsune, Yutaka Imai. Am J Hypertens 2006
38
25

The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity.
Alessandra Fiorentini, Antonio Perciaccante, Rosita Valente, Alberto Paris, Pietro Serra, Luigi Tubani. Auton Neurosci 2010
26
25

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Philip Greenland, Joseph S Alpert, George A Beller, Emelia J Benjamin, Matthew J Budoff, Zahi A Fayad, Elyse Foster, Mark A Hlatky, John McB Hodgson, Frederick G Kushner,[...]. Circulation 2010
460
25

QTc interval and scintigraphically assessed myocardial perfusion in newly diagnosed and long-term type 1 diabetes mellitus.
M Meier, D Muhr, M Weiss, K Tatsch, E Standl, O Schnell. J Diabetes Complications 2000
7
25

Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes.
Hiroshi Okada, Michiaki Fukui, Muhei Tanaka, Shinobu Matsumoto, Yusuke Mineoka, Naoko Nakanishi, Mai Asano, Masahiro Yamazaki, Goji Hasegawa, Naoto Nakamura. Diabetes Care 2013
49
25


Review of 1027 patients with newly diagnosed multiple myeloma.
Robert A Kyle, Morie A Gertz, Thomas E Witzig, John A Lust, Martha Q Lacy, Angela Dispenzieri, Rafael Fonseca, S Vincent Rajkumar, Janice R Offord, Dirk R Larson,[...]. Mayo Clin Proc 2003
25

Higher level of NT-proCNP in cerebrospinal fluid of patients with meningitis.
Ryszard Tomasiuk, Dariusz Lipowski, Stanislaw Szlufik, Krystyna Peplinska, Malgorzata Mikaszewska-Sokolewicz. Neurosci Lett 2016
2
50

Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.
Jung-Hsin Hsu, Yijiang Shi, Patrick Frost, Huajun Yan, Bao Hoang, Sanjai Sharma, Joseph Gera, Alan Lichtenstein. Oncogene 2004
41
25

The role of interleukin-1 beta in the pathogenesis of multiple myeloma.
J A Lust, K A Donovan. Hematol Oncol Clin North Am 1999
65
25



Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma.
H I Sati, M Greaves, J F Apperley, R G Russell, P I Croucher. Br J Haematol 1999
73
25


Ropinirole treatment in Parkinson's disease associated with higher serum level of inflammatory biomarker NT-proCNP.
Ryszard Tomasiuk, Stanislaw Szlufik, Andrzej Friedman, Dariusz Koziorowski. Neurosci Lett 2014
8
25




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.